Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections

10.1038/sj.onc.1205006

10.1124/mol.63.3.678

10.1136/bjo.83.10.1153

10.3727/096504001108747855

10.1099/0022-1317-81-3-639

Andrei, G., R. Snoeck, J. Piette, P. Delvenne, and E. De Clercq. 1998. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines. Oncol. Res.10:523-531.

Andrei, G., R. Snoeck, J. Piette, P. Delvenne, and E. De Clercq. 1998. Inhibitory effects of cidofovir (HPMPC) on the growth of the human cervical carcinoma (SiHa) xenografts in athymic-nude mice. Oncol. Res.10:533-539.

10.1128/AAC.41.3.587

10.1055/s-2001-19119

10.1177/095632029700800610

10.1183/09031936.01.17408300

Badiaga, S., P. Parola, C. Zandotti, and P. Brouqui. 1998. Successful treatment of Kaposi's sarcoma with a combination of antiviral drug therapy and chemotherapy: two case reports. Clin. Infect. Dis.27:1558.

10.1038/eye.1999.89

10.1080/15257779508010709

10.1016/S0002-9394(14)70781-0

10.1086/514057

10.1086/341491

10.1128/AAC.46.8.2381-2386.2002

Bendele, R. A., and F. C. Richardson. 2002. Adefovir nephrotoxicity and mitochondrial DNA depletion. Hum. Pathol.33:574.

10.1016/S0140-6736(01)05840-8

10.1086/313593

10.1097/00005537-200204000-00019

10.1097/00007890-200202270-00033

10.1016/S0006-2952(99)00118-5

10.1128/AAC.46.5.1610-1613.2002

10.1128/AAC.46.3.716-723.2002

10.1086/517060

10.1097/00042560-199705010-00014

10.1038/sj.bmt.1702591

10.1086/319984

Bosi, A., B. Bartolozzi, A. M. Vannucchi, A. Orsi, S. Guidi, and P. Rossi Ferrini. 2002. Polymerase chain reaction-based “pre-emptive” therapy with cidofovir for cytomegalovirus reactivation in allogeneic hematopoietic stem cells transplantation recipients: a prospective study. Haematologica87:446-447.

10.1007/s004150050440

10.1086/315190

10.1016/S0166-3542(01)00220-0

10.1067/moe.2000.110413

10.1046/j.1468-3083.2000.00184.x

10.1136/bjo.86.8.932

10.1086/314052

Cherrington, J. M. 1997. Human cytomegalovirus: resistance profile of cidofovir. Int. Antiviral News5:91-92.

10.1128/AAC.40.9.2212

10.1093/infdis/173.4.987

10.1067/mhn.2002.125604

10.1128/AAC.45.9.2495-2501.2001

10.1016/S0166-3542(00)00124-8

10.1128/AAC.45.4.1201-1209.2001

10.1124/mol.56.3.570

10.1016/S0166-3542(01)00210-8

10.1006/viro.1998.9299

10.1135/cccc19920661

Cihlar, T., and M. S. Chen. 1996. Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells. Mol. Pharmacol.50:1502-1510.

10.1177/095632029700800302

10.1076/ocii.7.3.223.3999

10.1016/0006-2952(93)90670-R

10.1086/318447

10.1128/AAC.45.10.2740-2745.2001

10.2165/00003088-199936020-00004

10.1128/AAC.42.3.687

10.1378/chest.118.4.1210

10.1016/S0140-6736(99)01782-1

10.1067/mjd.2000.100534

10.1016/0006-2952(91)90276-B

10.1002/rmv.1980030205

10.1002/rmv.1980050305

De Clercq E. 1996. Therapeutic potential of cidofovir (HPMPC, Vistide™) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. Verh. K. Acad. Geneeskd. Belg.58:19-49.

10.1016/S0924-8579(97)00031-9

10.1128/CMR.14.2.382-397.2001

10.1016/S0166-3542(02)00008-6

10.1016/S0165-6147(02)02091-6

10.1128/AAC.35.4.701

10.1002/rmv.336

10.1086/514150

10.1128/AAC.42.9.2380

10.1128/AAC.46.5.1586-1588.2002

10.1128/AAC.46.2.425-433.2002

10.1212/WNL.52.4.891

10.1080/13550280152537256

10.1097/00002030-200001280-00006

10.1086/515153

10.1016/0166-3542(95)00962-0

10.1046/j.1365-2133.2001.04101.x

10.1016/S0166-3542(00)00080-2

10.1081/NCN-100002496

10.1128/CMR.7.1.1

Fife, K., J. Gill, D. Bourboulia, B. Gazzard, M. Nelson, and M. Bower. 1999. Cidofovir for the treatment of Kaposi's sarcoma in an HIV-negative homosexual man. Br. J. Dermatol.141:1136-1153.

10.1097/00002030-200109070-00013

10.1016/0166-3542(95)00985-X

10.1080/13550280152537274

10.1002/jmv.1084

10.1046/j.1365-2893.1999.00182.x

González-Fraile, M. I., C. Canizo, D. Caballero, R. Hernández, L. Vázquez, C. López, A. Izarra, J. L. Arroyo, A. de la Loma, M. J. Otero, and J. F. San Miguel. 2001. Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis. Transplant. Infect. Dis.3:44-46.

10.1097/00003226-199609000-00018

10.1056/NEJMoa021812

10.1086/318120

Hammoud, Z., D. M. Parenti, and G. L. Simon. 1998. Abatement of cutaneous Kaposi's sarcoma associated with cidofovir treatment. Clin. Infect. Dis.26:1233.

Hänel, M., F. Fiedler, and C. Thorns. 2001. Anti-CD20 monoclonal antibody (rituximab) and cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement. Onkologie24:491-494.

10.1128/AAC.46.4.1067-1072.2002

10.1136/sti.76.2.143

10.1001/archopht.119.10.1487

10.1016/S0161-6420(02)00992-2

Ho, H.-T., K. L. Woods, J. J. Bronson, H. De Boeck, J. C. Martin, and M. J. M. Hitchcock. 1992. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine. Mol. Pharmacol.41:197-202.

10.1053/bbmt.2001.v7.pm11529489

10.1128/AAC.44.4.1041-1046.2000

10.1080/000155500750012333

10.1086/515167

Johnson, A. A., A. S. Ray, J. Hanes, Z. Suo, J. M. Colacino, K. S. Anderson, and K. A. Johnson. 2001. Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. J. Biol. Chem.276:40848-40857.

10.1016/S0166-3542(01)00223-6

10.1001/jama.282.24.2305

10.1001/archopht.117.7.925

10.1172/JCI119380

10.1128/AAC.46.4.991-995.2002

10.1086/515534

10.1016/S0161-6420(95)30985-2

10.1016/S0002-9394(14)71233-4

10.1002/jmv.1036

10.1046/j.1365-2133.2002.04747.x

Kramata, P., I. Votruba, B. Otová, and A. Holý. 1996. Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases α, λ and ε. Mol. Pharmacol.49:1005-1011.

10.1093/toxsci/44.2.97

10.1097/00042560-199804010-00008

10.7326/0003-4819-126-4-199702150-00001

10.1086/516542

10.1093/infdis/171.4.788

10.1093/infdis/170.3.570

10.1001/archderm.134.9.1169

10.1038/sj.bmt.1702820

10.1128/AAC.45.5.1444-1449.2001

10.1002/1097-0215(200102)9999:9999<::AID-IJC1183>3.0.CO;2-K

Liekens, S., G. Andrei, M. Vandeputte, E. De Clercq, and J. Neyts. 1998. Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovir. Cancer Res.58:2562-2567.

Liekens, S., J. Neyts, E. De Clercq, E. Verbeken, D. Ribatti, and M. Presta. 2001. Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir. Cancer Res.61:5057-5064.

10.1182/blood.V97.2.388

10.1086/517101

10.1097/00002030-200305230-00006

10.1056/NEJMoa020681

10.1097/00002030-200206140-00004

10.1097/00126334-200305010-00003

10.1097/00007435-200106000-00007

10.1097/00002030-200110190-00026

10.1001/archderm.1997.03890440061010

10.1097/00002030-199711000-00006

10.1016/0006-2952(92)90110-5

10.1086/314560

10.1097/00126334-200108150-00005

Murono, S., N. Raab-Traub, and J. S. Pagano. 2001. Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs. Cancer Res.61:7875-7877.

10.1136/gut.49.6.860

Naeger, L. K., N. A. Margot, and M. D. Miller. 2001. Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication. Antiviral Ther.6:115-126.

10.1081/NCN-100002340

10.1128/AAC.46.7.2179-2184.2002

10.1177/095632029700800101

10.1016/S0166-3542(00)00130-3

10.1128/AAC.41.12.2754

10.1002/jmv.1890410312

10.1128/AAC.42.1.170

10.1007/BF01967257

10.1002/jmv.1890370112

Neyts, J., R. Sadler, E. De Clercq, N. Raab-Traub, and J. S. Pagano. 1998. The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice. Cancer Res.58:384-388.

10.1016/0042-6822(90)90271-R

10.1016/0166-3542(91)90057-X

10.2165/00003495-199958030-00010

10.1097/00002030-200202150-00017

10.1128/JVI.74.20.9771-9775.2000

10.1089/088922201316912772

Perrillo, R., E. Schiff, E. Yoshida, A. Statler, K. Hirsch, T. Wright, K. Gutfreund, P. Lamy, and A. Murray. 2000. Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology32:129-134.

10.1097/00007890-199912270-00017

10.1097/00007890-200104150-00010

10.2165/00003495-199958020-00015

10.1128/AAC.39.4.882

10.1053/jinf.2000.0704

Pransky, S. M., A. E. Magit, D. B. Kearns, D. R. Kang, and N. O. Duncan. 1999. Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch. Otolaryngol. Head Neck Surg.125:1143-1148.

Pransky, S. M., D. F. Brewster, A. E. Magit, and D. B. Kearns. 2000. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis. Arch. Otolaryngol. Head Neck Surg.126:1239-1243.

10.1016/S1386-6532(99)00069-4

10.4065/76.11.1171

10.1056/NEJM198703123161106

10.1046/j.1365-2133.2000.03769.x

10.1016/0166-3542(95)00058-5

10.1086/517222

10.1016/S0166-3542(01)00166-8

Romanowski, E. G., S. P. Bartels, and Y. J. Gordon. 1999. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model. Investig. Ophthalmol. Visual Sci.40:378-384.

Romanowski, E. G., and Y. J. Gordon. 2000. Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model. Investig. Ophthalmol. Visual Sci.41:460-463.

10.1128/AAC.42.11.2996

10.1007/s100720170031

10.1097/00002030-200206140-00008

10.1097/00002030-200005260-00029

Schürmann, D., F. Bergmann, M. P. Grobusch, M. Behnsch, and A. Liekfeld. 1998. Lack of efficacy of cidofovir in treating AIDS-related cytomegalovirus retinitis after long-term treatment with ganciclovir. AIDS12:678-679.

10.1023/A:1012108719462

10.1097/00126334-200003010-00002

Simonart, T., J.-C. Noel, E. De Clercq, and R. Snoeck. 1998. Abatement of cutaneous Kaposi's sarcoma associated with cidofovir treatment. Clin. Infect. Dis.27:1562.

Simonart, T., J.-C. Noel, G. De Dobbeleer, D. Parent, J.-P. Van Vooren, E. De Clercq, and R. Snoeck. 1988. Treatment of classical Kaposi's sarcoma with intralesional injections of cidofovir: report of a case. J. Med. Virol.55:215-218.

10.1128/AAC.36.9.1837

10.1016/S0166-3542(01)00159-0

Smee, D. F., K. W. Bailey, M.-H. Wong, and R. W. Sidwell. 2001. Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir. Antiviral Res.47:171-177.

10.1177/095632020101200105

10.1177/095632029700800612

10.1128/AAC.46.5.1329-1335.2002

10.1086/514041

10.1006/viro.2000.0609

10.1056/NEJM199309233291317

10.1002/(SICI)1096-9071(200002)60:2<205::AID-JMV16>3.0.CO;2-8

10.1086/322593

Snoeck, R., M. Van Ranst, G. Andrei, E. De Clercq, S. De Wit, M. Poncin, and N. Clumeck. 1995. Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue. N. Engl. J. Med.333:943-944.

10.1128/AAC.32.12.1839

10.1002/(SICI)1096-9071(199803)54:3<219::AID-JMV13>3.0.CO;2-C

10.1001/archinte.161.19.2382

10.1128/AAC.42.6.1484

10.1002/jmv.2213

Reference deleted.

10.1177/095632029700800102

10.1086/314496

10.1097/00042560-200203010-00001

10.1097/00042560-199904010-00001

10.1016/S0166-3542(02)00019-0

10.7326/0003-4819-126-4-199702150-00002

10.1097/00002030-200007280-00013

10.1016/S0002-9394(01)00840-6

Toro, J. R., L. V. Wood, N. K. Patel, and M. L. Turner. 2000. Topical cidofovir. A novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus type 1. Arch. Dermatol.136:983-985.

10.1126/science.270.5239.1197

10.1089/aid.1997.13.707

Tsai, C.-C., P. Emau, J. C. Sun, T. W. Beck, C.-A. Tran, K. E. Follis, N. Bischofberger, and W. R. Morton. 2000. Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection. J. Med. Primatol.29:248-258.

10.1002/jmv.1890450221

10.1128/AAC.40.11.2586

10.1086/322781

10.1128/JVI.74.4.1767-1774.2000

10.1128/JVI.73.4.2947-2955.1999

10.1086/318497

10.1097/00007890-200301150-00020

10.1136/gut.49.3.436

Westland, C. E., H. Yang, W. E. Delaney IV, C. S. Gibbs, M. D. Miller, M. Wulfsohn, J. Fry, C. L. Brosgart, and S. Xiong. 2003. Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B. Hepatology38:96-103.

10.1177/014556130007900407

10.1128/AAC.41.3.594

10.1128/AAC.35.8.1596

10.1053/jhep.2002.34740

10.1001/jama.1997.03550150040032

10.1016/S0190-9622(98)70046-5

Zabawski, E. J., Jr., and C. J. Cockerell. 1999. Topical cidofovir for molluscum contagiosum in children. Pediatr. Dermatol.16:414-415.

Zimmermann, T., K. Stingele, M. Hartmann, J. Haas, R. von Einsiedel, and B. Wildemann. 2001. Succesful treatment of AIDS related PML with HAART and cidofovir. Eur. J. Med. Res.6:190-192.